Taiho Pharmaceutical Co, Ltd. announces that it and Astex Pharmaceuticals (UK), both Otsuka group companies, have granted an exclusive licence under their joint, small-molecule drug discovery programme targeting SHP2, to Merck & Co., Inc., Kenilworth, NJ, USA, known as MSD outside the United States and Canada through a subsidiary.
Astex Pharmaceuticals™ is a leader in innovative drug discovery, development and commercialization, committed to the fight against cancer and other life-threatening diseases.
Telephone: +44 (0)1223 226 200
436 Cambridge Science Park Milton Road Cambridge
Post Code: CB4 0QA
Country: United Kingdom
Membership Type: Corporate 51+